Old Web
English
Sign In
Acemap
>
authorDetail
>
Deepti Behl
Deepti Behl
Sutter Medical Center
Medicine
Performance status
Randomized controlled trial
Pathology
Metastatic Pancreatic Adenocarcinoma
3
Papers
123
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Patterns of use of medical cannabis in a community oncology clinic.
2020
Journal of Clinical Oncology
Deepti Behl
Stacy D. DAndre
Carol Parise
Show All
Source
Cite
Save
Citations (1)
Phase IB/II Randomized Study of FOLFIRINOX Plus Pegylated Recombinant Human Hyaluronidase Versus FOLFIRINOX Alone in Patients With Metastatic Pancreatic Adenocarcinoma: SWOG S1313
2019
Journal of Clinical Oncology
Ramesh K. Ramanathan
Shannon McDonough
Philip A. Philip
Sunil R. Hingorani
Jill Lacy
Jeremy S. Kortmansky
Jaykumar Thumar
E. Gabriela Chiorean
Anthony F. Shields
Deepti Behl
Paul Tracy Mehan
Rakesh Gaur
Tara Elisabeth Seery
Katherine A. Guthrie
Howard S. Hochster
Show All
Source
Cite
Save
Citations (102)
A phase IB/II randomized study of mFOLFIRINOX (mFFOX) + pegylated recombinant human hyaluronidase (PEGPH20) versus mFFOX alone in patients with good performance status metastatic pancreatic adenocarcinoma (mPC): SWOG S1313 (NCT #01959139).
2018
Journal of Clinical Oncology
Ramesh K. Ramanathan
Shannon McDonough
Philip A. Philip
Sunil R. Hingorani
Jill Lacy
Jeremy S. Kortmansky
Jaykumar Thumar
E. Gabriela Chiorean
Anthony F. Shields
Deepti Behl
Paul Tracy Mehan
Rakesh Gaur
Tara Elisabeth Seery
Katherine A. Guthrie
Howard S. Hochster
Show All
Source
Cite
Save
Citations (20)
1